Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 3.8 Mln
May 23 (Reuters) - Stayble Therapeutics AB STABL.ST :
* Q1 EBIT LOSS SEK 3.8 MILLION VERSUS LOSS SEK 7.5 MILLION
YEAR
AGO
* Q1 NET LOSS SEK 3.7 MILLION VERSUS LOSS SEK 7.6 MILLION
YEAR AGO
Source text for Eikon: ID:nWkrjW9jY
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln